Jasper Bos, PhD, General Partner; Regina Salvat, PhD, Partner; and Roberto Hofmann, PhD, Senior Analyst will attend the 2026 BofA China Trailblazers Biotech Conference, taking place 5–6 November in Shanghai, China.
The conference brings together multinational pharmaceutical companies, regional biopharma businesses, healthcare-focused institutional investors from the US and Europe, and selected China-based pharmaceutical and biotechnology companies.
Organised by BofA, the event offers a focused programme of one-to-one and group meetings, alongside a lunch panel and networking reception. It provides a forum for investors and industry leaders to exchange perspectives, explore partnership and investment opportunities, and build connections across China’s rapidly evolving biopharma ecosystem.